SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 68 filers reported holding SORRENTO THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $890,000 | +82.0% | 187,423 | -8.0% | 0.00% | – |
| Q4 2018 | $489,000 | -69.2% | 203,690 | -43.5% | 0.00% | -100.0% |
| Q3 2018 | $1,588,000 | +15.7% | 360,774 | +89.2% | 0.00% | 0.0% |
| Q2 2018 | $1,373,000 | +264.2% | 190,708 | +100.0% | 0.00% | – |
| Q1 2017 | $377,000 | -29.9% | 95,345 | -13.2% | 0.00% | – |
| Q4 2016 | $538,000 | -53.2% | 109,818 | -26.0% | 0.00% | -100.0% |
| Q3 2016 | $1,149,000 | -11.8% | 148,406 | -36.2% | 0.00% | 0.0% |
| Q2 2016 | $1,303,000 | +2.0% | 232,757 | -2.0% | 0.00% | 0.0% |
| Q1 2016 | $1,277,000 | -15.2% | 237,389 | +37.3% | 0.00% | 0.0% |
| Q4 2015 | $1,506,000 | +3.8% | 172,919 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,451,000 | -39.7% | 172,919 | +26.6% | 0.00% | -50.0% |
| Q2 2015 | $2,406,000 | – | 136,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 15,001 | $1,410 | 0.00% |
| KLCM Advisors, Inc. | 20,000 | $1,880 | 0.00% |
| AlphaMark Advisors, LLC | 3,135 | $0 | 0.00% |
| TRUST CO OF VERMONT | 204 | $19 | 0.00% |
| SlateStone Wealth, LLC | 30,866 | $3 | 0.00% |
| Coppell Advisory Solutions LLC | 100 | $89 | 0.00% |
| Highlander Capital Management, LLC | 1,200 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Russell Investments Group, Ltd. | 266 | $25 | 0.00% |
| OGOREK ANTHONY JOSEPH /NY/ /ADV | 3,600 | $0 | 0.00% |